Dr. Denzil Louis Moraes, MD

Dr. Moraes practices at Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana.

Dr. Moraes' NPI, 1952381980, was assigned on January 17, 2006. Dr. Moraes holds Louisiana license 13759R.

Dr. Moraes' primary practice is Regional Eye Surgery Center - Baton Rouge, at 7777 Hennessey Blvd, Suite 5000, Baton Rouge, LA 70808. The practice phone is (225) 214-6688.

Dr. Moraes' primary practice is Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana. Dr. Moraes is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Moraes to 4 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moraes practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Moraes' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Moraes is licensed in Louisiana.

CMS data shows 11,123 Medicare services from Dr. Moraes across 29 procedure codes in 2024, for 1,557 Medicare patients. Medicare paid $318,408 for them.

CMS counts 1,557 Medicare patients who saw Dr. Moraes in 2024. The largest group is 65 to 74, with 662 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moraes' median patient age at 66, with 53% women.

In 2024, Dr. Moraes wrote 10,497 Medicare Part D claims for 1,475 patients. 80% of them were for generic drugs. CMS names the drug for 10,163 of them, across 68 drugs with 11 or more claims each, at $2,271,788 in total drug cost. In 2023, CMS named 13,006 claims across 70 drugs.

Dr. Moraes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moraes as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Moraes, published from 2012 to 2024. The most frequent topics are Heart Failure. Dr. Moraes' most frequent co-authors are Florina Corpodean, Iryna Popiv, DO and Philip R. Schauer, MD.

Dmand AI links Dr. Moraes to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Myocardial Infarction and Infarction.

CMS Open Payments shows 2,167 general payments to Dr. Moraes from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $549,556.